Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 4/20 | 1.00 |
| ▸ | CA2 | P00918 | 4/20 | 1.00 |
| ▸ | CA9 | Q16790 | 4/20 | 1.00 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 3/20 | 1.00 |
| ▸ | LMNA | P02545 | 1/20 | 1.00 |
| ▸ | CA5A | P35218 | 1/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 1.00 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 1.00 |
| ▸ | HSD17B1 | P14061 | 4/20 | 0.61 |
| ▸ | HSD17B2 | P37059 | 4/20 | 0.61 |
| ▸ | CA1 | P00915 | 3/20 | 0.61 |
| ▸ | TSHR | P16473 | 3/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.61 |
| ▸ | ACHE | P22303 | 2/20 | 0.61 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.61 |
| ▸ | CA7 | P43166 | 1/20 | 0.61 |
| ▸ | LCK | P06239 | 1/20 | 0.57 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Resorcinol SCHEMBL15515 | 1.00 | — | — | |
| Resorcinol SCHEMBL7945602 | 0.96 | — | — | |
| Resorcinol SCHEMBL6842721 | 0.96 | — | — | |
| Resorcinol SCHEMBL3984288 | 0.96 | CA12 (0.92) | CA12CA2CA9CA14ALDH1A1 | |
| Resorcinol SCHEMBL8442393 | 0.96 | — | — | |
| Resorcinol SCHEMBL1236660 | 0.96 | — | — | |
| Resorcinol SCHEMBL11880713 | 0.96 | — | — | |
| Resorcinol SCHEMBL8517218 | 0.96 | CA12 (0.92) | CA12CA2CA9CA14ALDH1A1 | |
| Resorcinol SCHEMBL20577903 | 0.96 | — | — | |
| Resorcinol SCHEMBL464804 | 0.96 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 115 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7811711-B2 | Formed by fusion with carbon fibers, gelation, supercritical solvent extraction, and pyrolysis; for electrolytic fuel cells and batteries | Lawrennce Livermore National Security, LLC (US) | 2010-10-12 | — | — | US | claimed |
| US-20090032770-A1 | Insoluble and Branched Polyphosphonates and Methods Related Thereto | FRX POLYMERS, LLC (US) | 2009-02-05 | — | — | US | claimed |
| US-20090017339-A1 | Formed by fusion with carbon fibers, gelation, supercritical solvent extraction, and pyrolysis; for electrolytic fuel cells and batteries | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC | 2009-01-15 | — | — | US | claimed |
| US-7410718-B2 | Formed by fusion with carbon fibers, gelation, supercritical solvent extraction, and pyrolysis; for electrolytic fuel cells and batteries | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC (US) | 2008-08-12 | — | — | US | claimed |
| US-20060258762-A1 | Hydrocarbon or hydrofluorocarbon blown ASTM E-84 class I rigid polyurethane foams | BAYER MATERIALSCIENCE LLC | 2006-11-16 | — | — | US | claimed |
| CN-1583696-A | Preparation of bisphenols salts | CHANGCHUN APPLIED CHEMISTRY (CN) | 2005-02-23 | — | — | CN | claimed |
| EP-0711744-B1 | Method for making acyl substituted resorcinols | GEN ELECTRIC (US) | 2000-04-05 | — | — | EP | claimed |
| EP-0043680-B1 | PROCESS FOR REMOVING CONTAMINANTS FROM A TIN SURFACE | AMCHEM PRODUCTS, INC. (US) | 1984-12-05 | — | — | EP | claimed |
| EP-3684762-B1 | COUMARIN DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND USES THEREOF FOR THE TREATMENT OF CANCER | LEAD DISCOVERY CENTER GMBH (DE) | 2023-05-03 | — | — | EP | disclosed |
| EP-1556009-B2 | COSMETIC AND PHARMACEUTICAL FOAM | FOAMIX PHARMACEUTICALS LTD (IL) | 2021-07-21 | — | — | EP | disclosed |
| US-11062794-B2 | Olfactory signature and odorant mixture having the same | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2021-07-13 | — | — | US | disclosed |
| US-20200291011-A1 | COUMARIN DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND USES THEREOF FOR THE TREATMENT OF CANCER | LEAD DISCOVERY CENTER GMBH (DE) | 2020-09-17 | — | — | US | disclosed |
| EP-3706709-A1 | DENTAL COMPOSITION WITH HIGH E-MODULUS | 3M Innovative Properties Company (US) | 2020-09-16 | — | — | EP | disclosed |
| EP-3684762-A1 | COUMARIN DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND USES THEREOF FOR THE TREATMENT OF CANCER | Lead Discovery Center GmbH (DE) | 2020-07-29 | — | — | EP | disclosed |
| US-4442163-A | IMPROVED ADHESION OF RUBBER VULCANIZATES | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1984-04-10 | — | — | US | disclosed |
| US-4426313-A | Preparation of surfactants by sulfonating derivatives of depolymerized coal | UOP INC. (US) | 1984-01-17 | — | — | US | disclosed |
| US-4381949-A | IMPROVED ADHESION TO RUBBER REINFORECMENT | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1983-05-03 | — | — | US | disclosed |
| US-4283567-A | FROM HIGH BOILING BY-PRODUCTS IN THE PRESENCE OF AMMONIUM SULFATE OR BISULFATE | MITSUI PETROCHEMICAL INDUSTRIES LTD. (JP) | 1981-08-11 | — | — | US | disclosed |
| US-3968174-A | MULTISTAGE | HALCON INTERNATIONAL, INC. (US) | 1976-07-06 | — | — | US | disclosed |
| US-3965033-A | Process for the production of oil-containing microcapsules | FUJI PHOTO FILM CO., LTD. (JA) | 1976-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200291011-A1 | COUMARIN DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND USES THEREOF FOR THE TREATMENT OF CANCER | POLRMT, UQCRC2, UQCRC1 | CA12 4467/4885CA2 4068/4885CA9 3495/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.